English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Low dose PFDA induces DNA damage and DNA repair inhibition by promoting nuclear cGAS accumulation in ovarian epithelial cells Journal article
Qin, Yuhenng, Yuan, Xiaoyu, Cui, Zhenyan, Chen, Wenhan, Xu, Sinan, Chen, Kelie, Wang, Fang, Zheng, Fang, Ni, Heng, Shen, Han Ming, Wu, Yihua, Xia, Dajing. Low dose PFDA induces DNA damage and DNA repair inhibition by promoting nuclear cGAS accumulation in ovarian epithelial cells[J]. Ecotoxicology and Environmental Safety, 2023, 265, 115503.
Authors:  Qin, Yuhenng;  Yuan, Xiaoyu;  Cui, Zhenyan;  Chen, Wenhan;  Xu, Sinan; et al.
Favorite | TC[Scopus]:6  IF:6.2/6.3 | Submit date：2023/11/01
Cgas  Dna Damage  Homologous Recombination (Hr)  Ovarian Epithelial Cells  Pfda  
Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage Journal article
Wu, Xiaobing, Guo, Maoni, Cui, Jian, Cai, Haoyang, Wang, San Ming. Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage[J]. Oncogenesis, 2022, 11(1), 41.
Authors:  Wu, Xiaobing;  Guo, Maoni;  Cui, Jian;  Cai, Haoyang;  Wang, San Ming
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:5.9/6.0 | Submit date：2022/08/02
Homologous Recombination  Cancer Susceptibility  Breast-cancer  Dna-damage  Deficiency  Repair  End  Amplification  Association  Expression  
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome Journal article
HAO, DP, LI, JJ, WANG, JL, ZHAO, ZQ, Wang, L., Di, L.. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome[J]. Theranostics, 2019, 3952-3965.
Authors:  HAO, DP;  LI, JJ;  WANG, JL;  ZHAO, ZQ;  Wang, L.; et al.
Favorite |   IF:12.4/12.0 | Submit date：2023/08/30
Ovarian cancer  Estrogen signaling  Deficiency of homologous-recombination  Chemotherapy  Hormone replacement  
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome Journal article
Dapeng Hao, Jingjing Li, Jianlin Wang, Yuan Meng, Zhiqiang Zhao, Chao Zhang, Kai Miao, Chuxia Deng, Benjamin K. Tsang, Li Wang, Li-jun Di. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome[J]. THERANOSTICS, 2019, 9(13), 3952-3965.
Authors:  Dapeng Hao;  Jingjing Li;  Jianlin Wang;  Yuan Meng;  Zhiqiang Zhao; et al.
Favorite | TC[WOS]:15 TC[Scopus]:15  IF:12.4/12.0 | Submit date：2020/05/21
Ovarian Cancer  Estrogen Signaling  Deficiency Of Homologous-recombination  Chemotherapy  Hormone Replacement  
CRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells Journal article
Xianglian Ge, Haitao Xi, Fayu Yang, Xiao Zhi, Yanghua Fu, Ding Chen, Ren-He Xu, Ge Lin, Jia Qu, Junzhao Zhao, Feng Gu. CRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells[J]. Molecular Therapy - Nucleic Acids, 2016, 5, E393.
Authors:  Xianglian Ge;  Haitao Xi;  Fayu Yang;  Xiao Zhi;  Yanghua Fu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:6.5/6.7 | Submit date：2018/12/20
Aav  Crispr/cas9  Homologous Recombination  Human Embryonic Stem Cells  Next Generation Sequencing  Nrl